NDC 82922-045 - Truemed Group LLC
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 82922-045
- Package NDCs from labels
- 82922-045-08
- Manufacturer
- Truemed Group LLC
- Effective date
- 2022-08-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| IMIQUIMOD - Truemed Group LLC | Truemed Group LLC | 2022-08-11 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Imiquimod | IMIQUIMOD | Sun Pharmaceutical Industries, Inc. | 51913a5a-1cab-4b9e-b2c2-e0174062df73 | 2026-01-21 | Warnings, Adverse reactions | P1QW714R7M |
| Imiquimod | IMIQUIMOD | Bryant Ranch Prepack | 9291e5cd-b83d-4b43-88f5-30cac6cef5ff | 2025-11-05 | Warnings, Adverse reactions | P1QW714R7M |
| Imiquimod | IMIQUIMOD | Bryant Ranch Prepack | f8db59e2-8052-413b-9f9f-07cd9eea07ec | 2025-09-25 | Warnings, Adverse reactions | P1QW714R7M |
| Imiquimod | IMIQUIMOD | Sun Pharmaceutical Industries, Inc. | 59af8153-4cf8-4f22-9000-f239798d52d1 | 2025-08-11 | Boxed warning, Warnings, Adverse reactions | P1QW714R7M |
| Imiquimod | IMIQUIMOD | Bryant Ranch Prepack | 47d3045f-a145-4095-bb8a-c67ba1ff3bda | 2025-07-29 | Warnings, Adverse reactions | P1QW714R7M |
| Imiquimod | IMIQUIMOD | Teva Pharmaceuticals USA, Inc. | 9f2cbefd-f295-47e2-8a9e-3e7c5812c963 | 2025-06-30 | Warnings, Adverse reactions | P1QW714R7M |
| Imiquimod | IMIQUIMOD | Oceanside Pharmacueticals | d86eeb0e-70e0-4c72-aaa3-37daa1d8611e | 2025-06-03 | Warnings, Adverse reactions | P1QW714R7M |
| Zyclara | IMIQUIMOD | Bausch Health US, LLC | 28cd9b5b-680b-480f-b33d-9c5b52bbf03d | 2025-05-23 | Warnings, Adverse reactions | P1QW714R7M |
| Imiquimod | IMIQUIMOD | Glenmark Pharmaceuticals Inc., USA | 663e39a9-a29e-473f-89ec-4c7c6bc27b8a | 2025-01-23 | Warnings, Adverse reactions | P1QW714R7M |
| IMIQUIMOD | IMIQUIMOD | DIRECT RX | a18a3f7e-7254-56c0-e053-2a95a90a7036 | 2025-01-17 | Warnings, Adverse reactions | P1QW714R7M |
| ed8b1991-a39a-9528-e053-2a95a90a4d4b | e5fdf3a0-dcf9-32af-e053-2a95a90af880 | 2022-11-15 | e5fdf3a0-dcf9-32af-e053-2a95a90af880 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.